ENOVIX CORP (ENVX)       12.785  +0.54 (+4.37%)

12.785  +0.54 (+4.37%)

US2935941078 - Common Stock


Fundamental Rating

4

Taking everything into account, ENVX scores 4 out of 10 in our fundamental rating. ENVX was compared to 86 industry peers in the Electrical Equipment industry. While ENVX has a great health rating, but there are worries on its profitability. While showing a medium growth rate, ENVX is valued expensive at the moment.




Profitability

Profitability Rating

1

The Piotroski-F score of ENVX is 4.00. This is a neutral score and indicates average health and profitability for ENVX.
ENVX has negative profitability rations, so we won't be analyzing them here.

ENVX has a Return On Assets of -26.74%. This is below the industry average of -11.58%.
ENVX's Profit Margin of -2446.84% is worse than the rest of the industry. The industry average Profit Margin is -25.08%. 94% of the industry peers have a better Profit Margin.
VS Industry

ROA (-26.74%) VS Industry: 34% outperformed.

-190.82
43.03

Profit Margin (-2446.84%) VS Industry: 6% outperformed.

-37,039.07
33.94

Valuation

Valuation Rating

1

When comparing the current price to the book value of ENVX, we can conclude it is valued correctly. It is trading at 5.61 times its book value.
ENVX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year ENVX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
When comparing the price book ratio of ENVX to the average industry price book ratio of 2.76, ENVX is valued more expensive than its industry peers.
VS Industry

Price/Book (5.61) VS Industry: 22% outperformed.

2,669.96
0.15

Growth

Growth Rating

4

ENVX is expected to show a strong growth in Revenue. In the coming 5 years, the Revenue will grow by 382.81% yearly.
ENVX is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 0.59% yearly.

ENVX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -61.39%.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -61.39% -2.98% -12% -0.93% 0.59%
RevenueN/A N/A N/A 452.12% 329.69% 459.18% 382.81%

Health

Health Rating

9

ENVX has a Current Ratio of 20.28. This indicates that ENVX is financially healthy and has no problem in meeting its short term obligations.
ENVX is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 2.25. ENVX has a better rating than 96% of its industry peers.
ENVX has a Quick Ratio of 20.26. This indicates that ENVX is financially healthy and has no problem in meeting its short term obligations.
ENVX is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.48. ENVX has a better rating than 97% of its industry peers.

The Debt to Equity ratio of ENVX is way better than the industry averages.
ENVX has an Altman-Z score of 9.54. This indicates that ENVX is financially healthy and little risk of bankruptcy at the moment.
ENVX has one of the better Altman-Z scores in its industry. It is much better than the industry average of 2.08. ENVX has a better score than 91% of its industry peers.
ENVX has a Piotroski-F score of 4.00. This indicates an average health and profitability for ENVX.
VS Industry

Debt/Equity (0) VS Industry: 73% outperformed.

10.41
0.00

Quick Ratio (20.26) VS Industry: 97% outperformed.

0.36
28.86

Current Ratio (20.28) VS Industry: 96% outperformed.

0.71
28.86

Altman-Z (9.54) VS Industry: 91% outperformed.

-21.84
3,072.38

Dividend

Dividend Rating

0

ENVX does not give a dividend.

ENVX Daily chart

ENOVIX CORP12.785

NASDAQ:ENVX (11/30/2022, 2:07:05 PM)+0.54 (+4.37%)

Chartmill FA Rating
GICS Sector Industrials
GICS IndustryGroup Capital Goods
GICS Industry Electrical Equipment
Earnings (Last) 11-01 2022-11-01/amc Earnings (Next) 03-01 2023-03-01
Ins Owners 3.35% Inst Owners 55.97%
Market Cap 2.01B Analysts 82.67
Valuation
PE N/A Fwd PE N/A
PEG (NY) N/A PEG (5Y) N/A
P/S 393.14 P/B 5.61
EV/EBITDA -14.74
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A
Growth
EPS 1Y -61.39% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q -87.5%
EPS Next Y -2.98% EPS Next 2Y -12%
EPS Next 3Y -0.93% EPS Next 5Y 0.59%
Revenue growth 1Y N/A Revenue growth 3Y N/A
Revenue growth 5Y N/A Revenue growth Q2Q N/A
Revenue Next Year 452.12% Revenue Next 2Y 329.69%
Revenue Next 3Y 459.18% Revenue Next 5Y 382.81%
Health
Current Ratio 20.28 Quick Ratio 20.26
Altman-Z 9.54 F-Score 4
Debt/Equity 0 WACC N/A
ROIC/WACC N/A
Profitability
ROA -26.74% ROE N/A
ROICexgc N/A ROIC N/A
PM -2446.84% OM -2184.13%
Asset Turnover 0.01

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA